Status:
RECRUITING
Ototoxicity in Patients With MoM Hip Bearings
Lead Sponsor:
Reinier Haga Orthopedisch Centrum
Collaborating Sponsors:
Reinier de Graaf Groep
Erasmus Medical Center
Conditions:
Ototoxic Hearing Loss
Cobalt Poisoning
Eligibility:
All Genders
Brief Summary
The goal of this observational study is to learn about ototoxicity in patients with a MoM hip arthroplasty. The main question it aims to answer is: • What is the prevalence of hearing loss in patient...
Eligibility Criteria
Inclusion
- all MoM patients from the different clinics
- revision MoM
- willing to participate
- speak/write the Dutch language
Exclusion
- Not willing to participate
- previous ENT surgery or ENT pathology
Key Trial Info
Start Date :
February 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06885411
Start Date
February 1 2023
End Date
December 1 2025
Last Update
March 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reinier de Graaf Ziekenhuis
Delft, Netherlands